Prevention of ovarian hyperstimulation syndrome in a rat model: efficacy comparison between cabergoline and meloxicam

References

• Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril. 1978;30:255–68.
   PubMed Web of Science ®Google Scholar
• Gomez R, Simon C, Remohi J, Pellicer A. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod. 2003;68:2164–71.
   PubMed Web of Science ®Google Scholar
• Gomez R, Simon C, Remohi J, Pellicer A. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology. 2002;143:4339–48.
   PubMed Web of Science ®Google Scholar
• Amarin ZO. Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome. An aggressive, but perhaps life-saving procedure. Hum Reprod. 2003;18:659–64.
   Google Scholar
• Gomez R, Gonzalez-Izquierdo M, Zimmermann RC, Novella-Maestre E, Alonso-Muriel I, Sanchez-Criado J, Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model. Endocrinology. 2006;147:5400–11.
   PubMed Web of Science ®Google Scholar
• Quintana R, Kopcow L, Marconi G, Young E, Yovanovich C, Paz DA. Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model. Fertil Steril. 2008;90:1511–16.
   Google Scholar
• Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by human granulose and theca/lutein cells. Role in corpus luteum development. Am J Pathol. 1995;146:157–65.
   PubMed Web of Science ®Google Scholar
• Yan Z, Weich HA, Bernart W, Breckwoldt M, Neulen J. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulose cells in vitro. J Clin Endocrinol Metab. 1993;77:1723–5.
   PubMed Web of Science ®Google Scholar
• Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/VP factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. 1995;80:1967–71.
   PubMed Web of Science ®Google Scholar
• Wang TH, Horng SG, Chang CL, Wu HM, Tsai YJ, Wang HS, Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. J Clin Endocrinol Metab. 2002;87:3300–8.
   PubMed Web of Science ®Google Scholar
• Kuenen BC, Tabernero J, Baselga J, Cavalli F, Pfanner E, Conte PF, Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma Clin Cancer Res. 2003;9:1648–55.
   PubMed Web of Science ®Google Scholar
• Glade-Bender J, Kandel JJ, Yamashiro DJ. VEGF blocking therapy in the treatment of cancer. Expert Opin Biol Ther. 2003;3:263–76.
   PubMed Web of Science ®Google Scholar
• Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med. 2001;7:569–74.
   PubMed Web of Science ®Google Scholar
• Mornex R, Orgiazzi J, Hugues B, Gagnaire JC, Claustrat B. Normal pregnancies after treatment of hyperprolactinemia with bromoergocryptine, despite suspected pituitary tumors. J Clin Endocrinol Metab. 1978;47:290–5.
   PubMed Web of Science ®Google Scholar
• Robert E, Musatti L, Piscitelli G, Ferrari CI. Pregnancy outcome after treatment with the ergot derivative, cabergoline. Reprod Toxicol. 1996;10:333–7.
   PubMed Web of Science ®Google Scholar
• Goldsman MP, Pedram A, Dominguez CE, Ciuffardi I, Levin E, Asch RH. Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil Steril. 1995;63:268–72.
   PubMed Web of Science ®Google Scholar
• Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB. Vascular endothelial growth factor localization in human ovary and follopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab. 1996;81:353–9.
   PubMed Web of Science ®Google Scholar
• Otani N, Minami S, Yamoto M, Shikone T, Otani H, Nishiyama R, The vascular endothelial growth factor/fms-like tyrosine kinaz system in human ovary during the menstrual cycle and early pregnancy. J Clin Endocrinol Metab. 1999;84:3845–51.
   PubMed Web of Science ®Google Scholar
• Bata MS, Al-Ramahi M, Salhab AS, Gharaibeh MN, Schwartz J. Delay of ovulation by meloxicam in healthy cycling volunteers: a placebo-controlled, double-blind, crossover study. J Clin Pharmacol. 2006;46:925–32.
   PubMed Web of Science ®Google Scholar
• Athanasiou S, Bourne TH, Khalid A, Okokon EV, Crayford TJ, Hagström HG, Effects of indomethacin on follicular structure, vascularity, and function ovary the periovulatory period in women. Fertil Steril. 1996;65:556–60.
   PubMed Web of Science ®Google Scholar
• Landgren BM, Unen AL, Dicfalusy E. Hormonal profile of the cycle in 68 normally menstruating women. Acta Endocrinol. 1980;94:89–98.
   PubMedGoogle Scholar
• Smith G. Roberts R, Hall C, Nuki G. Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with anti-inflammatory arthritis taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol. 1996;35:458–62.
   PubMedGoogle Scholar
• Akil M, Amos RS, Stewart P. Infertility may sometimes be associated with NSAID consumption. Br J Rheumatol. 1996;35:76–8.
   PubMedGoogle Scholar
• Mendonca L, Khamashta M, Nelson-Piercy El, Hunt BJ, Hughes GR. Nonsteroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology. 2000;39:880–2.
   PubMed Web of Science ®Google Scholar